17 episodi
Trials and PIs with Dr Michael Gibson theheart.org
-
- Scienze
What you need to know about today’s top cardiovascular trials in five minutes flat. Join Dr C Michael Gibson for brief interviews with the principal investigators
-
- video
Trials and PIs with Dr Michael Gibson #17: DANPACE with Dr Jens C Nielsen
Dr Jens C Nielsen (Aarhus University Hospital, Denmark) discusses DANPACE: the Danish multicenter randomized trial on single-lead atrial vs dual chamber pacing in sick sinus syndrome.
Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29. -
- video
Trials and PIs with Dr Michael Gibson #16: ANTIPAF with Dr Andreas Goette
Dr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial.
Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31. -
- video
Trials and PIs with Dr Michael Gibson #15: AVERROES with Dr Stuart J Connolly
Dr Stuart Connolly (McMaster University, Hamilton, ON) discusses AVERROES: apixaban vs acetylsalicylic acid to prevent strokes.
Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30. -
- video
Trials and PIs with Dr Michael Gibson #14: FUTURA OASIS 8 with Dr Sanjit Jolly
Dr Sanjit Jolly (McMaster University, Hamilton, ON) discusses FUTURA OASIS 8: a randomized trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux.
Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31. -
- video
Trials and PIs with Dr Michael Gibson #13: RESPONSE with Dr Ron J Peters
Dr Ron J Peters (University of Amsterdam, the Netherlands) discusses RESPONSE: effect of a nurse-coordinated prevention program on cardiovascular risk after an acute coronary syndrome.
Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31. -
- video
Trials and PIs with Dr Michael Gibson #12: Double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD with Dr Shinya Goto
Dr Shinya Goto (Tokai University, Isehara, Japan) discusses the double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD.
Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.